v v v v v v vv
ntal Hygienist 9th Edition
v v v v
by Elena Bablenis Haveles, Chapters 1 - 26
v v v v v v v v
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription Writi
v v v v v v v v v v
ng
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
v v v v v v v v
MULTIPLEvCHOICE
1. Knowledgevofvpharmacologyvaidsvthevdentalvprofessionalvin
a. obtainingvavpatient’svhealthvhistory.
b. administeringvdrugsvinvthevoffice.
c. handlingvemergencyvsituations.
d. selectionvofvavnonprescriptionvmedication.
e. Allvofvthev above.
ANSWER:v E
Allvofvthevchoicesvarevtrue.vBecausevmanyvofvourvpatientsvarevbeingvtreatedvwithvdrugs,vknowledgevofvph
armacologyvhelpsvinvunderstandingvandvinterpretingvpatients’vresponsesvtovhealthvhistoryvquestions.vKno
wledgevofvthevtherapeuticvandvadverseveffectsvofvmedicationsvobviouslyvhelpsvinvtheirvpropervadministra
tionvinvthevoffice.vEmergencyvsituationsvmayvbevcausedvbyvdrugsvorvtreatedvbyvdrugs;vthus,vknowledgevo
fvpharmacologyvisvofvgreatvhelp,vespeciallyvbecausevavrapidvresponsevisvsometimesvrequired.vAvclearvund
erstandingvofvthevconceptsvofvdrugvaction,vdrugvhandlingvbyvthevbody,vandvdrugvinteractionsvwillvallowvt
hevdentalvpractitionervtovmakevpropervjudgmentsvandvgraspvthevconceptsvrelevantvtovnewvdrugvtherapiesv
onvthevmarket.
DIF: Application
REF:v RolevofvthevDentalvHygienistv(Medication/HealthvHistory),vRolevofvthevDentalvHygienistv(Medicationv
Administration),vRolevofvthevDentalvHygienistv(EmergencyvSituations),vRolevofvthevDentalvHygienistv(Nonp
rescriptionvMedication)v|vpp.v2-3 OBJ: 1
TOP:v NBDHE,v6.0.vPharmacology
2. Whichvofvthevfollowingvstatementsvisvtruevregardingvplanningvappointments?
a. Whethervorvnotvpatientsvarevtakingvmedicationvforvsystemicvdiseasesvisvofvlittle
consequencevinvthevdentalvoffice.
b. Asthmaticvpatientsvshouldvhavevdentalvappointmentsvinvthevmorning.
c. Diabeticvpatientsvusuallyvhavevfewervproblemsvwithvavmorningvappointment
comparedvwithvafternoonvappointments.
d. BothvBvandvCvarevtrue.
ANSWER:v D
Asthmaticvpatientsvwhovexperiencevdentalvanxietyvshouldvschedulevtheirvappointmentsvwhenvtheyvarevno
tvrushedvorvundervpressurevearlyvinvthevmorning.vDiabeticvpatientsvusuallyvhavevrelativelyvfewervproble
msvwithvavmorningvappointment.vPatientsvtakingvmedicationvforvsystemicvdiseasesvmayvrequirevspecialvh
andlingvinvthevdentalvoffice.
,DIF: Comprehension
REF:v RolevofvthevDentalvHygienistv(AppointmentvScheduling)v|vp.v3v
OBJ:v 1 TOP:v NBDHE,v6.0.vPharmacology
, 3. Nutritionalvorvherbalvsupplements
a. carryvthevU.S.vFoodvandvDrugvAdministrationv(FDA)vapprovalvforvdiseasevstates.
b. arevnotvdrugs.
c. canvcausevadverseveffects.
d. willvnotvinteractvwithvothervdrugsvthevpatientvmayvbevtaking.
ANSWER:v C
Nutritionalvorvherbalvsupplementsvarevquitevcapablevofvcausingvadverseveffects.vThevmajorityvofvn
utritionalvorvherbalvsupplementsvdovnotvcarryvFDAvapprovalvforvtreatingvdiseasevstates.vThesevsu
pplementsvarevdrugsvandvcanvcausevadverseveffectsvandvinteractvwithvdifferentvdrugs.
DIF:v v Comprehension
REF:v RolevofvthevDentalvHygienistv(NutritionalvorvHerbalvSupplements)v|vp.v3v
OBJ:v 1 TOP:v NBDHE,v6.0.vPharmacology
4. Whichvtypevofvdrugvnamevusuallyvbeginsvwithvavlowercasevletter?
a. Brandvname
b. Codevname
c. Genericvname
d. Tradevname
ANSWER:v C
Beforevanyvdrugvisvmarketed,vitvisvgivenvavgenericvnamevthatvbecomesvthev“official”vnamevofvthevdrug.vEa
chvdrugvisvassignedvonlyvonevgenericvnamevselectedvbyvthevU.S.vAdoptedvNamevCouncil,vandvthevnamevi
svnotvcapitalized.vThevbrandvnamevisvequivalentvtovthevtradevnamevandvisvcapitalized.vAlthoughvthevbrand
vnamevisvtechnicallyvthevnamevofvthevcompanyvmarketingvthevproduct,vthisvtermvisvoftenvusedvinterchange
ablyvwithvthevtradevname.vThevcodevnamevisvthevinitialvtermvusedvwithinvavpharmaceuticalvcompanyvtovre
fervtovavdrugvwhilevitvisvundergoingvinvestigationvandvisvoftenvavcombinationvofvcapitalvlettersvandvnumb
ers,vthevlettersvrepresentingvanvabbreviationvofvthevcompanyvname.
DIF: Comprehension
REF:v DrugvNamesv|vp.v4vOBJ:v 3
TOP:v NBDHE,v6.0.vPharmacology
5. Avdrug’svgenericvnamevisvselectedvbyvthe
a. pharmaceuticalvcompanyvmanufacturingvit.
b. FoodvandvDrugvAdministrationv(FDA).
c. U.S.vAdoptedvNamevCouncil.
d. FederalvPatentv Office.
ANSWER:v C
Eachvdrugvisvassignedvonlyvonevgenericvnamev(e.g.,vibuprofen).vItvisvselectedvbyvthevU.S.vAdoptedvName
vCouncil.vThevgenericvnamevisvnotvselectedvbyvthevFDAvorvthevFederal vPatentvOffice.vThevpharmaceutic
alvcompanyvmanufacturingvthevdrugvclearlyvhasvanvinfluencevonvthevgenericvnamevgivenvitsvdrug,vbutvthev
finalvdecisionvisvnotvthevcompany’s.
DIF: Recall REF:v DrugvNamesv|vp.v4
OBJ:v 3vTOP:v NBDHE,v6.0.vPharmacology